AIM Global to Develop Health Care Test Protocols
October 21, 2008 // Published as a news service by IHS
| |
| Medical Device Documents |
IHS medical device collections contain EU Directives and Harmonized Standards from BSI, CEN, CENELEC and ETSI.
ASTM standards are also available.
Please complete this form for a free quote. |
|
| |
AIM Global's radio frequency identification (RFID) Experts Group (REG) will develop a set of test protocols for testing of RF emitters to ensure a benign effect in a health care setting.
Three test protocol suites were identified and will examine:
- RF emissions and the susceptibility of medical devices including implantables and wearables.
- RF emissions and clinical instrument susceptibility.
- The effects of RF on pharmaceuticals, biologics, blood products and human physiology.
The test protocols initially will focus on the 11 different International Organization for Standardization (ISO)/International Electrotechnical Commission (IEC) standards for RFID and real time location systems and will also explore the applicability of the Institute of Electrical and Electronics Engineers (IEEE) 802.11 standards.
After the test protocols are developed, they will be submitted to the U.S. Federal Drug Administration (FDA) for comment and approval. Once approved, the test protocols for certification for health care use will be available through licensing with the test protocol developers.
Development of the test protocols will involve collaboration with Georgia Tech, the University of Pittsburgh and the University of Texas at Arlington.
The universities conducting the testing will work with the equipment manufacturers and, if there are negative results, assist in resolving issues between interference and susceptibility, said AIM Global.
Source: AIM Global.